000 -LEADER |
fixed length control field |
04944cam a2200397Ii 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20250319150529.0 |
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS--GENERAL INFORMATION |
fixed length control field |
m o d |
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
fixed length control field |
cr un|---aucuu |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
250319b ||||| |||| 00| 0 eng d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9783527349470 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9783527833818 |
Qualifying information |
(electronic bk. : oBook) |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
3527833811 |
Qualifying information |
(electronic bk. : oBook) |
024 7# - OTHER STANDARD IDENTIFIER |
Standard number or code |
10.1002/9783527833818 |
Source of number or code |
doi |
035 ## - SYSTEM CONTROL NUMBER |
System control number |
(OCoLC)1289932184 |
041 ## - LANGUAGE CODE |
Language code of text/sound track or separate title |
eng. |
050 #4 - LIBRARY OF CONGRESS CALL NUMBER |
Classification number |
HD9665.5 |
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
Classification number |
615.19 |
Edition number |
23 |
100 1# - MAIN ENTRY--PERSONAL NAME |
Preferred name for the person |
Behme, Stefan, |
Authority record control number |
http://id.loc.gov/authorities/names/nb2009004450 |
Relator term |
author. |
245 10 - TITLE STATEMENT |
Title |
Manufacturing of pharmaceutical proteins : |
Remainder of title |
from technology to economy / |
Statement of responsibility, etc |
Stefan Behme. |
250 ## - EDITION STATEMENT |
Edition statement |
Third edition. |
264 #1 - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
Place of publication, distribution, etc |
Weinheim, Germany : |
Name of publisher, distributor, etc |
Wiley-VCH, |
Date of publication, distribution, etc |
2022. |
300 ## - PHYSICAL DESCRIPTION |
Extent |
1 online resource. |
336 ## - CONTENT TYPE |
Content type term |
text |
Content type code |
txt |
Source |
rdacontent. |
337 ## - MEDIA TYPE |
Media type term |
computer |
Media type code |
c |
Source |
rdamedia. |
338 ## - CARRIER TYPE |
Carrier type term |
online resource |
Carrier type code |
cr |
Source |
rdacarrier. |
504 ## - BIBLIOGRAPHY, ETC. NOTE |
Bibliography, etc |
Includes bibliographical references and index. |
505 0# - CONTENTS |
Formatted contents note |
Introduction. Biopharmaceutical Production: Value Creation, Product Types, and Biological Basics Introduction -- Technology -- Technology. Manufacturing Process -- Analytics -- Pharmacy -- Pharmacy. Pharmacology and Drug Safety -- Quality Assurance -- Quality Assurance. Fundamentals of Quality Assurance -- Quality Assurance in Manufacturing -- Pharmaceutical Law -- Pharmaceutical Law. Pharmaceutical Law and Regulatory Authorities -- Production Facilities -- Production Facilities. Facility Design -- Planning, Construction, and Commissioning of a Manufacturing Plant -- Economy -- Economy. Production Costs -- Investments -- Production Concept -- Production Organization and Digitalization -- Production Organization and Digitalization. Organization of a Manufacturing Facility -- Digitalization. |
520 ## - SUMMARY, ETC. |
Summary, etc |
An expert, single-volume overview of the core processes and disciplines of biopharmaceutical production<br/><br/>In the newly revised Third Edition of Manufacturing of Pharmaceutical Proteins: From Technology to Economy, renowned chemical engineer Dr. Stefan Behme delivers a comprehensive text covering all aspects of biopharmaceutical manufacturing, including legal and regulatory considerations, production facility design, quality assurance, supply chain management, emerging market regulations, and cost control. Suitable as both a reference book and a training resource, this book extensively explores the impact of digital transformation on pharmaceutical protein manufacturers and includes a brand-new chapter dedicated to digitalization.<br/><br/>The distinguished author provides readers with practical understanding of the terminology and principles driving the various fields involved with biotechnological production, including operations, legal, finance, and IT. He also offers:<br/><br/>A thorough introduction to biopharmaceutical production, including value creation, product types, and biological basics<br/>Comprehensive explorations of the technology of the manufacturing process and analytics<br/>Practical discussions of pharmacology and drug safety, quality assurance, and pharmaceutical law<br/>In-depth examinations of pharmaceutical protein production facilities, including facility design and the planning, construction, and commissioning of a manufacturing plant<br/>Perfect for biotechnologists working in the pharmaceutical industry, Manufacturing of Pharmaceutical Proteins: From Technology to Economy will also earn a place in the libraries of pharmaceutical engineers seeking a one-stop reference for all aspects of biopharmaceutical production. |
545 0# - BIOGRAPHICAL OR HISTORICAL DATA |
Biographical or historical note |
About the Author<br/>Stefan Behme, PhD, has held several positions within the pharma and biotech industry over the last 20 years with Bayer AG and former Schering AG, Germany. Trained as chemical engineer, his industrial assignments included: managing healthcare investment projects in Germany and the US, biotech manufacturing operations, strategic sourcing of finished pharmaceuticals, and quality assurance in one of the world’s largest drug manufacturing facilities. In parallel he has been passing on his knowledge to students of the Universities of Dortmund (Germany) and Berlin as lecturer for GMP-aspects of biopharmaceutical manufacturing and general life science manufacturing processes. In 2009 he published the first edition of the book “Manufacturing of Pharmaceutical Proteins: from Technology to Economy”, which has developed into a popular reference and was followed by a further expanded edition in 2015. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Pharmaceutical industry. |
Authority record control number |
http://id.loc.gov/authorities/subjects/sh85039713. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Protein drugs. |
Authority record control number |
http://id.loc.gov/authorities/subjects/sh92004729. |
655 #4 - INDEX TERM--GENRE/FORM |
Genre/form data or focus term |
Electronic books. |
856 40 - ELECTRONIC LOCATION AND ACCESS |
Link text |
Full text available at Wiley Online Library Click here to view. |
Uniform Resource Identifier |
https://onlinelibrary.wiley.com/doi/book/10.1002/9783527833818 |
942 ## - ADDED ENTRY ELEMENTS |
Source of classification or shelving scheme |
|
Item type |
EBOOK |